Centene Corporation (NYSE: CNC) today declared it has consented to a conclusive arrangement to acquire Apixio Inc., a healthcare investigation organization offering Artificial Intelligence (AI) innovation arrangements. The exchange is dependent upon administrative endorsements and is required to near to the furthest limit of 2020.
Apixio gives an innovation suite that mines, arranges and investigates huge volumes of dissimilar, unstructured patient information, (for example, doctor notes and clinical graphs), and makes and refines calculations to remove excellent bits of knowledge to help payers' and suppliers' regulatory exercises. Apixio's AI stage has been prepared to deal with the complexities and difficulties of the healthcare business and convey demonstrated outcomes.
"Centene is committed to accelerating innovation, modernization and digitization across the enterprise and solidify its position as a technology company focused on healthcare. Apixio's capabilities are closely aligned with our plans to digitize the administration of healthcare and to leverage comprehensive data to help improve the lives of our members," said Michael F. Neidorff, Chairman, President and Chief Executive Officer for Centene. "Apixio's technology will complement existing data analytics products including Interpreta, creating a differentiated platform to broaden support for value-based healthcare payment and delivery with actionable intelligence."
"We are very excited about this transaction. With Centene, we will be able to accelerate the use of our AI technology to improve the way that healthcare is measured, administered, and delivered, and to help enable new discoveries," said Darren Schulte, M.D., Chief Executive Officer for Apixio. "This partnership positions Apixio to extract insights from digital data to help millions of individuals receive higher quality care around the world."
Apixio will stay an operationally free substance as a component of Centene's Health Care Enterprises gathering to keep carrying an incentive to its customers and the business, while likewise understanding the advantages of upgraded scale with Centene.
About Centene Corporation
Centene Corporation, a Fortune 50 company, is a leading multi-national healthcare enterprise that is committed to helping people live healthier lives. The Company takes a local approach – with local brands and local teams – to provide fully integrated, high-quality, and cost-effective services to government-sponsored and commercial healthcare programs, focusing on under-insured and uninsured individuals. Centene offers affordable and high-quality products to nearly 1 in 15 individuals across the nation, including Medicaid and Medicare members (including Medicare Prescription Drug Plans) as well as individuals and families served by the Health Insurance Marketplace, the TRICARE program, and individuals in correctional facilities. The Company also serves several international markets, and contracts with other healthcare and commercial organizations to provide a variety of specialty services focused on treating the whole person. Centene focuses on long-term growth and the development of its people, systems and capabilities so that it can better serve its members, providers, local communities, and government partners.